South San Francisco, CA, United States of America

Rounak Feigelman

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rounak Feigelman: Pioneering Innovations in Bacterial Compositions

Introduction

Rounak Feigelman is an innovative inventor residing in South San Francisco, California. He has made significant contributions to the field of microbiology through his ground-breaking research on bacterial strains, which has resulted in one patent to date. His work aims to address various health disorders, highlighting the potential of bacteria in therapeutic applications.

Latest Patents

Rounak Feigelman holds a patent for "Compositions comprising bacterial species and methods related thereto." This patent focuses on specific bacterial strains of the genus, particularly the sp. P152-H6d strains. The disclosure encompasses not only the compositions that include these bacterial strains but also their use in preventing or treating various disorders, such as inflammatory, gastrointestinal, metabolic disorders, and dysbiosis.

Career Highlights

Currently, Rounak is associated with Xbiome Inc., a company dedicated to exploring the therapeutic uses of bacteria. His work involves rigorous research and innovation, positioning him as an essential figure within the company and the broader scientific community.

Collaborations

In his professional journey, Rounak collaborates with notable colleagues, including Peyman Akbari and Ali Akin. These partnerships foster creativity and synergy, further enhancing the potential impact of their collective research efforts on health and disease management.

Conclusion

Rounak Feigelman’s dedication to advancing the understanding and applications of bacterial species marks him as an important inventor in the field of microbiology. His patent and ongoing work at Xbiome Inc. illustrate the promising future of bacterial therapies in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…